The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Perrigo Company PLC

NYSE: PRGO
Last

(U.S.) $165.96

Today's change-0.15 -0.09%
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.
 

Perrigo Company PLC

NYSE: PRGO
Last

(U.S.) $165.96

Today's change-0.15 -0.09%
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.

Perrigo Company PLC down slightly

Perrigo Company PLC closed down just (U.S.)$0.15 Friday to (U.S.)$165.96. Shares have lost 1.30% over the last five days, but sit 3.27% below their 52-week high. This security has underperformed the S&P 500 by 4.33% during the last year.

Key company metrics

  • Open(U.S.) $166.36
  • Previous close(U.S.) $166.11
  • High(U.S.) $166.65
  • Low(U.S.) $165.24
  • Bid / Ask-- / --
  • YTD % change+8.15%
  • Volume231,439
  • Average volume (10-day)1,123,153
  • Average volume (1-month)889,150
  • Average volume (3-month)996,791
  • 52-week range(U.S.) $125.37 to (U.S.) $171.57
  • Beta0.30
  • Trailing P/E152.42×
  • P/E 1 year forward22.56×
  • Forward PEG1.55×
  • Indicated annual dividend(U.S.) $0.42
  • Dividend yield0.25%
  • Trailing EPS(U.S.) $1.09
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.10%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 27, 201409/27/2014Jun 28, 201406/28/2014Mar 29, 201403/29/2014Dec 28, 201312/28/2013
Revenue9521,1441,004979
Total other revenue--------
Total revenue9521,1441,004979
Gross profit322416315361
Total cost of revenue630728689618
Total operating expense8149479011,058
Selling / general / administrative146170148216
Research & development37384538
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)21120187
Other operating expenses, total--------
Operating income137198103-79
Interest income (expense), net non-operating-26------
Gain (loss) on sale of assets--------
Other--------
Income before tax10916663-113
Income after tax9613248-86
Income tax, total123415-27
Net income9613248-86
Total adjustments to net income--------
Net income before extra. items9613248-86
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9613248-86
Inc. avail. to common incl. extra. items9613248-86
Diluted net income9613248-86
Dilution adjustment------0
Diluted weighted average shares13413413499
Diluted EPS excluding extraordinary itemsvalue per share0.720.980.36-0.87
Dividends per sharevalue per share0.110.110.110.09
Diluted normalized EPSvalue per share0.731.050.470.38